Virtual Posters & Abstracts

Thank you for considering sharing your hematologic malignancies research outcomes with the healthcare community at the 2022 Lymphoma, Leukemia & Myeloma Congress. 

  • Increase Your Research Engagement. Seize the opportunity to present your work to more than 1,000+ attendees at one of the most respected forums for industry-leading hematologic research and clinical case studies
  • Get Published. Accepted abstracts will be published in the American Journal of Hematology and shared on the Oncology Learning Network
  • Receive Accolades. Each year the Congress Chairs recognize the “Best Of” submitted abstracts. Winning abstracts receive free congress registration

Accepted abstracts will be published in the American Journal of Hematology and shared with attendees as digital posters accessible online. Only abstracts received by the submission deadline will be published.

Abstract submissions are due August 15th, 2022.

Abstracts will be accepted in the following categories: Non-Malignant Hematology DiseasesAcute Leukemia & Myeloproliferative/Myelodysplastic Diseases, Multiple Myeloma, Chronic Lymphocytic Leukemia or Lymphoma. Please indicate which category applies to your abstract by checking the appropriate box in the online submission system.


Abstract Categories

Acute Leukemia & Myeloproliferative/Myelodysplatic Diseases  
A1. Clinical Trials
A2. Procedures and Diagnostics
A3. Epidemiology and Outcomes Research
A4. Clinical Case Reports
A5. Trials in Progress

Multiple Myeloma
M1. Clinical Trials
M2. Procedures and Diagnostics
M3. Epidemiology and Outcomes Research
M4. Clinical Case Reports
M5. Trials in Progress

Chronic Lymphocytic Leukemia 
C1. Clinical Trials
C2. Procedures and Diagnostics
C3. Epidemiology and Outcomes Research
C4. Clinical Case Reports
C5. Trials in Progress

L1. Clinical Trials
L2. Procedures and Diagnostics
L3. Epidemiology and Outcomes Research
L4. Clinical Case Reports
L5. Trials in Progress

Non-Malignant Hematology Diseases

N1. Clinical Trials
N2. Procedures and Diagnostics
N3. Epidemiology and Outcomes Research
N4. Clinical Case Reports
N5. Trials in Progress